Showing results (51-60 of 60) with videos related to
Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 60 results.
Anti-Cancer Drug Design|September 1, 1995
Prodrugs of anthracycline antibiotics suited for tumor-specific activationM Azoulay, J C Florent, C Monneret, et al.Anti-Cancer Drug Design|October 1, 1994
Prodrugs of anthracyclines for chemotherapy via enzyme-monoclonal antibody conjugatesJ P Gesson, J C Jacquesy, M Mondon, et al.Molecular Pharmacology|November 28, 2001
Induction of cyclin E and inhibition of DNA synthesis by the novel acronycine derivative S23906-1 precede the irreversible arrest of tumor cells in S phase leading to apoptosisS Léonce, V Pérez, S Lambel, et al.Phytochemistry|October 3, 2000
Sesquiterpene lactone and friedelane derivative from drypetes molunduanaJ Wandji, J D Wansi, V Fuendjiep, et al.Journal of Medicinal Chemistry|July 6, 2000
Synthesis and cytotoxic and antitumor activity of benzo[b]pyrano[3, 2-h]acridin-7-one analogues of acronycineN Costes, H Le Deit, S Michel, et al.Anti-Cancer Drug Design|July 16, 1999
Application of the ADEPT strategy to the MDR resistance in cancer chemotherapyS Desbene, H D Van, S Michel, et al.Journal of Medicinal Chemistry|November 22, 1996
Synthesis and cytotoxic and antitumor activity of esters in the 1,2-dihydroxy-1,2-dihydroacronycine seriesA Elomri, S Mitaku, S Michel, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 8, 2001
Marked antitumor activity of a new potent acronycine derivative in orthotopic models of human solid tumorsN Guilbaud, L Kraus-Berthier, F Meyer-Losic, et al.Natural Product Research|July 13, 2006
Triterpenoids from Drypetes chevalieri Beille (euphorbiaceae)J D Wansi, J Wandji, W A F Kamdem, et al.Journal of Medicinal Chemistry|September 11, 1998
Prodrugs of anthracyclines for use in antibody-directed enzyme prodrug therapyJ C Florent, X Dong, G Gaudel, et al.Pageof 6